Skip to main content
Signal8

Dissanaike Sharmila

SEC insider (Form 3/4/5 filer). CIK 0001885069. Director at HERON THERAPEUTICS, INC. /DE/ (HRTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in CARY, NC.

Companies Dissanaike Sharmila has filed insider reports for

  • HERON THERAPEUTICS, INC. /DE/ (HRTX): Director
Dissanaike Sharmila profile photo

Dissanaike Sharmila

CIK: 0001885069

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HERON THERAPEUTICS, INC. /DE/ logo
HRTX

HERON THERAPEUTICS, INC. /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 30, 2026
    Award
    Direct
    54K shares-
  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 31, 2025
    Award
    Direct
    18K shares-
  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 30, 2025
    Award
    Direct
    18K shares-

1-3 of 3